Economist David Rosenberg on why he’s so worried about a trade war with China      Shares of chipmaker NXP on wild ride amid conflicting reports about Chinese approval of Qualcomm bid     Twitter price target raised to $52 by UBS, citing World Cup     An online retailer has surged over 200% in one year, and it’s not Amazon     Even the greatest investors — including Buffett, Druckenmiller — make multibillion-dollar mistakes     Stocks making the biggest moves premarket: QCOM, T, SD, AAPL, FOXA, ADBE & more     Micron is doing something unusual ahead of next week's earnings     AIG chief investment officer Doug Dachille on the Fed's rate hike plan     Citigroup downgrades Kohl's, saying it has run too far, too fast     Oracle shares drop after JP Morgan downgrades on lost business to Amazon and Microsoft     The Fed just raised rates, here are three groups to buy     Stephen Bannon buys into bitcoin     With the Fed in the rearview mirror, the ECB’s big rate decision takes the stage     The SEC's policy on cryptocurrencies is confusing. That may be cleared up on Thursday     Former Federal Reserve Chair Greenspan says we're on 'the edge' of a trade war     Goldman Sachs' David Kostin on when interest rate movement becomes dangerous to stocks     An unlikely winner from the AT&T-Time Warner decision — CVS Health     'White-knuckle moments' are about to hit the bond market, money manager warns     Last time Twitter saw this kind of a rally, the stock hit pause before falling 20 percent     Millennials are dumping their individual stocks and flocking to ETFs, Schwab survey shows     Restoration Hardware-owner shares soar 34% on signs its shift to luxury is working     Fund managers are pouring money into US stocks, as profit outlook best in world      Twitter shares jump after JP Morgan raises price target, citing higher advertising sales     JP Morgan sees Weight Watchers rallying more than 20% as it adds more 'influencers' like Oprah     Urban Outfitters' upbeat quarterly forecast spurs price target hikes     Sage shares surge 15% after FDA OKs expedited depression drug development     El-Erian: Trump-Kim agreement allows market to focus on more pressing issue of the Fed     Tudor Jones says his social impact ETF has potential to rival the S&P 500     
AstroCycle
Free Market Forecasts
Mail-Us
CNBC
Twitter
Live
Transportation Cycle Analysis